Journal Information
Vol. 17. Issue 10.
Pages 570-574 (December 2021)
Vol. 17. Issue 10.
Pages 570-574 (December 2021)
Original Article
Full text access
Prevalence of osteoporosis in Colombia: Data from the National Health Registry from 2012 to 2018
Prevalencia de osteoporosis en Colombia: datos del registro nacional de salud del 2012 al 2018
Daniel G. Fernández-Ávilaa,b,d,
Corresponding author
, Santiago Bernal-Macíasa,b,d, María J. Parrab,d, Diana N. Rincónc,d, Juan M. Gutiérreza,b,d, Diego Rossellic,d
a Unidad de Reumatología, Departamento de Medicina Interna, Hospital Universitario San Ignacio, Bogotá, Colombia
b Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia
c Servicio Reumatología, Hospital Militar Central, Bogotá, Colombia
d Departamento de Epidemiología Clínica y Bioestadística, Facultad de Medicina Pontificia Universidad Javeriana, Bogotá, Colombia
This item has received
Article information
Full Text
Download PDF
Figures (2)
Tables (2)
Table 1. Patients seen with a primary diagnosis of osteoporosis by age group between 2012 and 2018.
Table 2. Patients diagnosed with osteoporosis by sex and age group between 2012 and 2018.
Show moreShow less

Osteoporosis is considered a healthcare problem due to the increased risk of fractures and high cost of care. In Colombia, the Ministry of Health introduced SISPRO, a tool to collect nationwide information from the health system. The information collected from SISPRO is available for scientific analysis. This article presents an analysis of the prevalence and characteristics of patients with osteoporosis using data from 2012 to 2018.


To estimate prevalence of osteoporosis between January 2012 to December 2018 and describe the patients’ demographic characteristics.


This is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems related to osteoporosis as search terms using the SISPRO database.


National records report 249,803 patients over 50 years old diagnosed with osteoporosis. The estimated prevalence is 2440 cases per 100,000 inhabitants over 50 years old (based on a total population of 10,236,132), being more frequent in women (92% of cases), with a female/male ratio of 12.3:1.


This study shows a lower prevalence than previous estimates or projections. Given these findings we think it is necessary to act to promote health policies for patients with osteoporosis.

Latin America

La osteoporosis es considerada un problema de salud pública, ya que, al aumentar el riesgo de fracturas, genera un alto coste para el sistema de salud. En Colombia, el Ministerio de Salud utiliza la herramienta SISPRO para recolectar información del sistema de salud. La información almacenada en SISPRO es pública y disponible para la investigación. Este artículo presenta un análisis de la prevalencia y características de los pacientes con osteoporosis a partir de los datos del 2012 al 2018.


Estimar la prevalencia de osteoporosis entre enero de 2012 a diciembre de 2018 y describir las características demográficas de los pacientes.


Estudio descriptivo de corte transversal en el que se tomaron los datos de SISPRO, utilizando como palabras clave los diagnósticos del manual internacional de enfermedades relacionados con el diagnóstico de osteoporosis.


Se documentaron 249.803 individuos mayores de 50 años con diagnóstico de osteoporosis, estimando una prevalencia de 2.440 casos por 100.000 habitantes mayores de 50 años (basado en una población total de 10.236.132), siendo más frecuente en mujeres (92%), con una relación mujer a hombre de 12,3:1.


Este estudio muestra una baja prevalencia respecto a las estimaciones y proyecciones. Dados estos resultados es necesario trabajar en promover políticas en salud para los pacientes con osteoporosis.

Palabras clave:
Full Text

Osteoporosis (OP) and fragility fractures are a public health problem due to the increase in morbidity and mortality that they generate. Because prevalence of the disease is directly proportional to age, OP is becoming increasingly frequent in a population that tends to live longer.1 However, OP is not on the agenda of public health priorities in Colombia, where other chronic diseases such as cancer, HIV infection, chronic kidney disease, cardiovascular disease, diabetes mellitus, among others, are the focus of the state budget and the interventions of health decision-makers.2 This paper aims to establish the prevalence of OP in Colombia, describe the basic demographic characteristics of patients with this disease and give visibility to a problem that is silent but with multiple repercussions on our country’s health system.

Material and method

A cross-sectional study was conducted based on official data from the Colombian Ministry of Health. The official data from the Colombian Ministry of Health come from an information collection and storage tool called the Integral Social Protection Information System (SISPRO), which has four components: health, pensions, occupational risks, and social promotion. The first component stores and processes the basic and minimum data required by the General System of Social Security in Health for management, regulation, and control processes. This data is entered from the Individual Registry of Health Service Delivery. The information contained in these databases is for public use. The dynamic tables that the Ministry of Health has online were consulted and the data were obtained to conduct this study. Information was obtained for Colombia for the period from 1 January 2012 to 31 December 2018, for which an analysis of the Individual Registry of Health Service Delivery databases was undertaken, using the international codes of diseases (ICD-10) for osteoporosis (M800, M801, M802, M803, M804, M805, M808, M809, M810, M811, M812, M813, M814, M815, M818, M819), and we analysed variables such as sex, type of insurance and distribution in five-year age groups, according to the official projections of the National Administrative Department of Statistics, based on the projections of the 2005 national census.3 The data collected were analysed with descriptive statistics, using means and measures of central tendency for quantitative variables and proportions for qualitative variables. Prevalence was adjusted by sex and age group to the 2015 population over 50 years of age, projected for each of the 32 departments during the period analysed. The diagnostic criteria for OP in the SISPRO database are not standardised; they depend on the clinical and diagnostic judgement of each physician when registering a patient with an ICD-10 code related to OP. Patients who were registered with a diagnosis of OP as the “principal diagnosis” were included. It is important to highlight that the coverage of the Colombian health system is one of the highest in Latin America (95.1%),4 which allows for a significant amount of data from the entire population of the country. This project was approved by our institution’s Central Research Committee.


We identified 249,803 cases (“persons attended”) with a principal diagnosis of OP, which allowed us to calculate an unadjusted prevalence of 2440 cases per 100,000 inhabitants over 50 years of age, and to establish that the condition is more frequent in women (92% of cases), with a female: male ratio of 12.3:1. An analysis of the prevalence of OP by five-year age groups shows an increase in prevalence as the population ages (Table 1 and Fig. 1). The number of patients according to sex and age group is presented in Table 2. It can be observed that the prevalence of OP is higher in women (4210 per 100,000 inhabitants) compared to men (395 per 100,000 inhabitants), and that prevalence increases as the population ages.

Table 1.

Patients seen with a primary diagnosis of osteoporosis by age group between 2012 and 2018.

Age group  2012  2013  2014  2015  2016  2017  2018  Total patients  Prevalence 
50–54  1,050  1,208  1,623  1,638  1,608  2,275  3,313  10,217  381 
55–59  2,786  3,135  4,404  4,234  4,545  6,481  8,638  24,571  1107 
60–64  5,453  5,894  7,573  7,267  8,025  10,916  13,059  37,910  2,193 
65–69  7,471  7,895  9,665  8,820  9,485  12,779  14,973  43,954  3,362 
70–74  7,660  7,853  9,172  8,150  8,748  11,638  13,546  40,570  4,377 
75–79  6,854  6,716  7,879  6,701  7,194  9,769  11,130  35,206  5,142 
80 or more  13,067  12,417  13,479  10,735  11,230  13,869  14,859  57,375  8,320 
Total  45,542  46,471  55,818  49,232  52,373  69,705  81,860  249,803  2,440 

The total patients’ column corresponds to the number of people seen at some point during the five-year period. Prevalence is calculated using the mean population of the period as the denominator × 100,000 inhabitants.

Fig. 1.

Non-age adjusted prevalence of patients with osteoporosis during the years 2012–2018. Prevalence is calculated with the mean population of the period as the denominator per 100,000 inhabitants.

Table 2.

Patients diagnosed with osteoporosis by sex and age group between 2012 and 2018.

Age group  Males with OP  Prevalence of OP (×100,000 inhab)  Males with fractures and OP  OP with fractures (%)  Prevalence of OP with fractures in COL (×100,000 inhab)  Females with OP  Prevalence of OP (×100,000 inhab)  Females with fractures and OP  OP with fractures (%)  Prevalence of OP with fractures in COL (×100,000 inhab) 
50–54  1033  81  192  19  15  9,184  654  1032  11  73 
55–59  1643  157  293  18  28  22,928  1957  2421  11  207 
60–64  2189  269  409  19  50  35,721  3904  4295  12  469 
65–69  2733  449  522  19  86  41,221  5901  5733  14  821 
70–74  2891  685  570  20  135  37,679  7463  6244  17  1237 
75–79  2826  950  619  22  208  32,380  8365  6666  21  1722 
80 or more  5445  1917  1493  27  526  51,930  12804  15490  30  3819 
Total  18760  395  4098  22  86  23,1043  4210  41881  18  763 

COL: Colombia; OP: osteoporosis.

We also analysed the presence of OP with fractures, which corresponded to 18% of the total cases of osteoporosis. Due to the characteristics of the Registry, it was not possible to establish the fracture site. In the analysis by sex, we observed that 22% of men with OP have fractures compared to 18% of women. Given these results, we undertook an analysis of the prevalence of OP with fracture adjusted for sex and age, which showed that the prevalence of OP with fracture is 1% in women and .1% in men.

Regarding the distribution of OP by department, we found that the national population-adjusted prevalence in men ranged between 2.3 and 206.2 per 100,000 inhabitants, while the adjusted prevalence in women was between 12 and 2190 per 100,000 inhabitants (Fig. 2). The areas with the highest adjusted prevalence in both men and women are three departments of the coffee-growing region: Risaralda (6.8 per 100,000 inhabitants), Antioquia (6.2 per 100,000 inhabitants) and Caldas (5.8 per 100,000 inhabitants).

Fig. 2.

Geographical distribution of the prevalence of osteoporosis for the period 2012–2018, adjusting for sex and age group of the Columbian population. Prevalence is calculated with the mean population of the period as the denominator per 100,000 inhabitants. (A) Males. (B) Females.


Colombia is in a process of demographic transition, as are other countries in the region, due to increased longevity of the population. Life expectancy according to the WHO for Colombia is 77 years, and when differentiated by sex, it is 80 years for women and 74 years for men.5,6 One of the notable consequences of this demographic phenomenon is an increase in the prevalence of chronic non-communicable diseases. This phenomenon has been documented worldwide in the case of OP, which is a disease considered a public health problem because it affects postmenopausal women and the elderly population, increasing the risk and incidence of fractures, with significant social and economic costs for health systems.7,8 It is estimated that approximately 200 million people suffer from OP worldwide, with a progressive increase associated with the global ageing of the population, although the prevalence of OP is difficult to establish, given its asymptomatic course until the onset of fractures.7–9

According to the projections of the International Osteoporosis Foundation’s report presented in 2012, it was evident that the data in Latin America were insufficient, but the estimates indicated that there were 1,423,559 women with OP in Colombia and 8000–10,000 hip fractures per year.2 However, the data obtained from the Ministry of Health registry reports only 249,803 people with OP, which is one-fifth of the estimate of the International Osteoporosis Foundation. Other work such as that by Morales-Torres et al. collected data from Latin America, where the range of vertebral OP was 7.6%–12.1% and of femoral neck OP was 7.9%–22%,8 which again is higher than that found in our study, where the overall prevalence is 2.4% in those over 50 years of age. A report from Bogota in 1999 reported a prevalence of OP of 32% in a group of patients who underwent bone scans,10 which again contrasts with the findings of the national registry.

The results of this study show that OP occurs more frequently in women of all age ranges and its prevalence increases in a directly proportional manner, which is in line with that reported in other studies in Latin America (LAVOS, Brazil)11,12 and in other regions (Spain, China, Canada).13–15 However, the lower prevalence than that reported in other studies may be due to under-diagnosis and under-recording in the SISPRO information system, as well as the difference in the methodology of the studies, since the methodology used to measure prevalence in the studies that we took as the reference for this article’s discussion was taking densitometry measurements of specific population groups using the active search mode, or by analysing hospital records in at-risk populations.

In terms of the prevalence of OP fractures, these are two to three times more common in women.16 Worldwide, about 8.9 million fractures per year are attributable to OP.16 However, there is likely to be under-reporting, because some fragility fractures are under-diagnosed and under-treated,17,18 leading to the functional impairment of sufferers, decreased quality of life and high mortality rates.11,16 In 2010, around 3.5 million fractures in Europe were attributed to OP, hip fracture being the most frequent.19 The LAVOS study, conducted in 5 Latin American countries (Argentina, Brazil, Colombia, Mexico and Puerto Rico) showed a standardised prevalence of vertebral fractures in women over 50 years of age of 11.18% (95% CI 9.23–13.4), which increases from 6.9% in women aged 50–59 years to 27.8% in women over 80 years.12 This direct relationship between ageing and increased prevalence of fractures is also determined by the findings of our study, as is the higher prevalence of OP among women.

The Colombian health system is based on single-payer public financing and mixed public and private provision, with almost universal coverage (95.1% according to the latest official measurement in June 2019).4 However, the main limitation of this study is underreporting, due to the characteristics of the Registry, which only records the main diagnoses, not comorbidities, which in the case of OP, as it is often a comorbidity, is not adequately recorded. Neither is it possible to calculate the incidence because there is no criterion to determine the “main diagnosis” from one year to another. As there can be variations in recording, it is not possible to calculate the incidence or duration of the disease.20 Also, due to the nature of the data, it is not possible to establish the course of the disease, the patients’ specific clinical characteristics, fracture sites, or response to treatment.

Our study shows information taken from the Colombian Ministry of Health database. From this information we made demographic and epidemiological analyses of the population and projections for the care of patients with OP in our country. These results alert us to the importance of improving the characteristics of the Registry, and of designing public health policies for a disease which is possibly being under-diagnosed and therefore, with a lower rate of treatment for patients.

Conflict of interests

The authors have no conflict of interests to declare.


We would like grateful to the members of the Department of Internal Medicine and Rheumatology for their comments which greatly contributed to this paper.

N. Harvey, E. Dennison, C. Cooper.
Osteoporosis: impact on health and economics.
Nat Rev Rheumatol, 6 (2010), pp. 99-105
Latin America regional audit. Epidemiología, costos e impacto de la osteoporosis en 2012. International Osteoporisis Foundation. 2012 [Accessed 10 October 2019]. Available from:
Departamento Administrativo Nacional de Estadística DANE.
Proyecciones de población.
Ministerio de Salud y Protección Social de Colombia.
Cobertura sistema de salud en Colombia.
Ministerio de Salud y Protección Social. Envejecimiento Demográfico. Colombia 1951-2020. Dinámica demográfica y estructuras poblacionales. Bogotá; 2013. 48 p.
United Nations, Department of Economic and Social Affairs PD (2019). World Population Prospects 2019. 2019 [Accessed 20 September 2019]. Available from:
J.Y. Reginster, N. Burlet.
Osteoporosis: a still increasing prevalence.
Bone, 38 2 SUPPL. 1 (2006), pp. 4-9
J. Morales-Torres, S. Gutiérrez-Ureña.
The burden of osteoporosis in Latin America.
Osteoporos Int, 15 (2004), pp. 625-632
L. Alonso González, G. María Vásquez, J. Fernando Molina.
Epidemiología de la osteoporosis epidemiology of osteoporosis.
Rev Colomb Reumatol, 16 (2009), pp. 61-75
A. Páez.
Densitometria ósea: utilidad diagnóstica.
Rev del Hosp Cent la Policía Nac, 2 (1999), pp. 27-31
B.C.G. Marinho, L.P. Guerra, J.B. Drummond, B.C. Silva, M.M.S. Soares.
The burden of osteoporosis in Brazil.
Arq Bras Endocrinol Metabol, 58 (2014), pp. 434-443
P. Clark, F. Cons-Molina, M. Deleze, S. Ragi, L. Haddock, J.R. Zanchetta, et al.
The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS).
Osteoporos Int, 20 (2009), pp. 275-282
J. Sanfélix-Genovés, B. Reig-Molla, G. Sanfélix-Gimeno, S. Peiró, M. Graells-Ferrer, M. Vega-Martínez, et al.
The population-based prevalence of osteoporotic vertebral fracture and densitometric osteoporosis in postmenopausal women over 50 in Valencia, Spain (the FRAVO study).
Y. Wang, Y. Tao, M.E. Hyman, J. Li, Y. Chen.
Osteoporosis in China.
Osteoporos Int, 20 (2009), pp. 1651-1662
J.E. Tarride, R.B. Hopkins, W.D. Leslie, S. Morin, J.D. Adachi, A. Papaioannou, et al.
The burden of illness of osteoporosis in Canada.
Osteoporos Int, 23 (2012), pp. 2591
O. Johnell, J.A. Kanis.
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures.
Osteoporos Int, 17 (2006), pp. 1726-1733
K.B. Freedman, F.S. Kaplan, W.B. Bikler, B.L. Strom, R.A. Lowe.
Treatment of osteoporosis: are physicians missing an opportunity?.
J Bone Jt Surg Am, 82 (2000), pp. 1063-1070
E.S. Siris, P.D. Miller, E. Barrett-Connor, K.G. Faulkner, L.E. Wehren, T.A. Abbott, et al.
Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the national osteoporosis risk assessment.
J Am Med Assoc, (2001),
E. Hernlund, A. Svedbom, M. Ivergård, J. Compston, C. Cooper, J. Stenmark, et al.
Osteoporosis in the European Union: medical management, epidemiology and economic burden.
Arch Osteoporos., 8 (2013), pp. 136
A. Méndez-Ayala, D. Nariño, D. Rosselli.
Burden of epilepsy in Colombia.
Neuroepidemiology, 44 (2015), pp. 144-148

Please cite this article as: Fernández-Ávila DG, Bernal-Macías S, Parra MJ, Rincón DN, Gutiérrez JM, Rosselli D. Prevalencia de osteoporosis en Colombia: datos del registro nacional de salud del 2012 al 2018. Reumatol Clin. 2021;17:570–574.

Copyright © 2020. Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología
Reumatología Clínica (English Edition)
Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?